Skip to main content
. 2021 Dec 30;14(12):e246432. doi: 10.1136/bcr-2021-246432

Table 2.

Baseline biochemical profile of the five patients who developed Graves’s disease following vaccination against SARS-CoV-2

Investigation Patient 17 Patient 27 Patient 38 Patient 48 Patient 5 Reference range
40-year-old woman 28-year-old woman 71-year-old woman 46-year-old man 71-year-old woman (case presentation)
Thyroid Stimulating Hormone <0.001 <0.001 <0.02 0.35–2.00 µ(IU)/mL
Free T4 3.57 1.84 3.56 1.63 7.2 0.9–1.7 ng/dL
Total T3 251 216 11.10 0.8–2.8 ng/mL
Free T3 10.5 9.2 5.18 5.30 2.02–4.4 pg/mL
Anti-TSH receptor Antibodies 16.56 5.85 4.2 2.9 0–1.75 UI/L
Thyroid stimulating immunoglobulin 380 347 <140% baseline

– shows lab value was not obtained or no value was available per patient records.